This study demonstrates the synthesis of an electrophilic hub using SuFEx chemistry for late-stage drug discovery, suggesting potential applications in targeted inhibition.
The development of electrophilic strained small motifs is of increasing importance for chemical biology and drug discovery, enabling precise, late‐stage functionalization and targeted covalent inhibition. In this work, we report the efficient synthesis of a novel azabicyclo[1.1.0]butyl‐substituted sulfonimidoyl fluoride, a bench‐stable electrophilic hub combining strain‐release reactivity and SuFEx chemistry. The dual reactivity of this motif was demonstrated through selective ABB ring‐opening reactions, and SuFEx‐mediated ligations with diverse nucleophiles, including pharmaceutically relevant derivatives. Further derivatization of the resulting sulfonimidates and sulfonimidamides showcased the synthetic versatility of this system. These findings open avenues for the development of modular, multifunctional platforms in drug discovery.
No takes yet. Share an insight, caveat, or question.
Şerbetçi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: